Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Partnered Liquid Tumor-2 by Isogenica for Hematological Tumor: Likelihood of Approval
Partnered Liquid Tumor-2 is under clinical development by Isogenica and currently in Phase II for Hematological Tumor. According to GlobalData,...